Suppr超能文献

择期经皮冠状动脉介入治疗后肌钙蛋白 I 升高:患病率和危险因素。

Troponin I Elevation after Elective Percutaneous Coronary Interventions: Prevalence and Risk Factors.

机构信息

Dr Alock Dev, Resident, Department of Cardiology, Chattogram Medical College (CMC), Chattogram, Bangladesh; E-mail:

出版信息

Mymensingh Med J. 2023 Jul;32(3):704-713.

Abstract

Percutaneous coronary intervention (PCI) is one of the most important modalities of treatment for coronary artery disease (CAD). Minor extents of injury to the myocardium have been observed even after successful PCI. This peri-procedural injury might therefore reduce some of the beneficial effects of coronary revascularization. The objective of this hospital based comparative observational study was to determine the prevalence of post procedural Cardiac troponin I (cTnI) elevation after elective PCI and also to find out the relation with risk factors such as age, sex, body mass index (BMI), smoking, anemia, diabetes mellitus, hypertension, dyslipidemia, family history, left ventricular dysfunction, renal insufficiency, type of stent, number of stent and length of stent. This was a hospital based comparative observational study carried out in the Department of Cardiology, Chattogram Medical College Hospital (CMCH), Chattogram, Bangladesh from July 2018 to June 2019. A total of 50 patients who underwent elective PCI were included as sampled by purposive sampling method. Serum cTnI was measured by FIA8000 quantitative immunoassay analyzer with an analytical measurement before and at 24 hours of PCI. Value >1.0ng/ml was considered elevated. Univariate and multivariate analysis were applied to assess predictors for the occurrence of post-procedural elevation of cTnI. The mean±SD age of the study population was 54.96±9.1 years (range 35-74 years) and 34(68.0%) patients were male. Regarding cardiovascular risk factors, 17(34.0%) patients had diabetes mellitus, 27(54.0%) had dyslipidemia, 30(60.0%) had hypertension, 32(64.0%) were current or ex-smokers and 20(40.0%) had a family history of CAD. Eighteen patients (36.0%) had post-procedural cTnI elevation but only 8(16.0%) had significant (>1.0ng/ml) elevation. Change of cTnI before and at 24 hours of PCI was not significant (p=0.057). Cardiac Troponin I increase was related to age, pre-procedural serum creatinine and multi-vessel stenting. Minor elevation of cTnI was common following elective PCI and associated with few risk factors such as elderly patient (more than 50 years), raised serum creatinine and multi-vessel stenting. So, early detection of these risk factors, as well as effective intervention may help to prevent injury to cardiac tissue hence stop elevation of cardiac TnI following elective PCI.

摘要

经皮冠状动脉介入治疗(PCI)是治疗冠状动脉疾病(CAD)的最重要手段之一。即使在 PCI 成功后,也观察到心肌受到轻微损伤。因此,这种围手术期损伤可能会降低冠状动脉血运重建的一些有益效果。本项基于医院的对比观察性研究旨在确定选择性 PCI 后心脏肌钙蛋白 I(cTnI)升高的发生率,并找出与年龄、性别、体重指数(BMI)、吸烟、贫血、糖尿病、高血压、血脂异常、家族史、左心室功能障碍、肾功能不全、支架类型、支架数量和支架长度等危险因素的关系。这是一项在孟加拉国 Chattogram 医学院医院(CMCH)心内科进行的基于医院的对比观察性研究,时间为 2018 年 7 月至 2019 年 6 月。通过目的抽样法共纳入 50 例接受选择性 PCI 的患者。采用 FIA8000 定量免疫分析分析仪测量血清 cTnI,在 PCI 前和 24 小时进行分析测量。>1.0ng/ml 被认为是升高的。应用单变量和多变量分析评估发生术后 cTnI 升高的预测因素。研究人群的平均年龄为 54.96±9.1 岁(35-74 岁),34 名(68.0%)患者为男性。在心血管危险因素方面,17 名(34.0%)患者患有糖尿病,27 名(54.0%)患者患有血脂异常,30 名(60.0%)患者患有高血压,32 名(64.0%)为现吸烟者或曾经吸烟者,20 名(40.0%)有 CAD 家族史。18 名患者(36.0%)术后 cTnI 升高,但只有 8 名(16.0%)有显著升高(>1.0ng/ml)。PCI 前和 24 小时的 cTnI 变化无显著差异(p=0.057)。肌钙蛋白 I 的增加与年龄、术前血清肌酐和多血管支架置入有关。选择性 PCI 后肌钙蛋白 I 轻度升高很常见,与一些危险因素有关,如老年患者(>50 岁)、血清肌酐升高和多血管支架置入。因此,早期发现这些危险因素并进行有效干预可能有助于防止心肌组织损伤,从而阻止选择性 PCI 后心脏 TnI 的升高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验